EN
HI
Cohance Lifesciences Chart
Cohance Lifesciences Share Key Metrics
Volume
3.03 L
Market Cap
16523.07 CR
LTQ@LTP
48@431.90
ATP
430.82
Var Margin
100 %
Circuit Range
339.45-509.15
Delivery %
83.79 %
Value
13.05 CR
ASM/GSM
No
Market Lot
1
Summary
Cohance Lifesciences share price is ₹431.9 as of 9 Jun, 2026. The stock Cohance Lifesciences intraday movement has stayed between ₹423.85 and ₹434.50, while on a 52-week basis,Cohance Lifesciences price 52 week high is ₹1121.15 & its 52 week low is ₹266.70.
In terms of trading activity, Cohance Lifesciences has recorded a volume of 302908 shares, The Cohance Lifesciences has a market cap of ₹382567140 CR. The stock’s Average Traded Price (ATP) stands at ₹430.82, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 48 @ ₹431.90.
Cohance Lifesciences operates within a circuit range of ₹339.45 – ₹509.15, with a Value of ₹13.05 CR. The Delivery Percentage for the day is 83.79%. Additionally, Cohance Lifesciences currently falls under the No framework, and trades with a market lot size of 1.
Cohance Lifesciences Fundamentals
P/E Ratio
90.54
P/B Ratio
4.15
Div. Yield
0
Sector P/E
67.41
Sector P/B
2.96
Sec. Div. Yield
0.54
Cohance Lifesciences Resistance and Support
Pivot 424.87
Resistance
First Resistance
429.44
Second Resistance
434.57
Third Resistance
439.14
Support
First Support
419.74
Second Support
415.17
Third Support
410.04
Cohance Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-12 | Audited Results |
| 2026-02-12 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-28 | Audited Results |
| 2025-02-12 | Quarterly Results |
Cohance Lifesciences News
Cohance Lifesciences Ltd - 543064 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Cohance Lifesciences launched a postal ballot for shareholders to approve the appointment of Mr. Umang Vohra as Chairman & Group CEO, effective May 2026. The ballot also includes his remuneration package, valued at USD 4.7 million annually, and the new Employee Stock Option Plan 2026 (ESOP 2026) which will result in a 7.75% capital dilution over 7.5 years. E-voting is scheduled from May 15 to June 13, 2026.
May 14 2026 18:11:03
Cohance Lifesciences Ltd - 543064 - Board Meeting Outcome for Outcome Of The Board Meeting
Cohance Lifesciences reported FY26 consolidated revenue of ₹22.69 bn (down 13% YoY) and net profit of ₹1.84 bn (down 65.4% YoY). The Q4 consolidated revenue declined 26.3% YoY to ₹6.19 bn, with net profit falling 76.5% YoY to ₹0.33 bn, influenced by inventory adjustments and pricing pressures. The Board also revised its KMP materiality policy.
May 12 2026 17:39:38
Cohance Lifesciences Management
| Name | Position |
|---|---|
| Vivek Sharma | Chairman |
| Umang Vohra | Additional Director |
Cohance Lifesciences Similar Stocks
Onesource Specialty Pharma Ltd.
1715.40
-22.40 (1.29%)
Pfizer Ltd.
4592.50
64.60 (1.43%)
Granules India Ltd.
765.05
-1.30 (0.17%)
Astrazeneca Pharma India Ltd.
8453.00
109.50 (1.31%)
Eris Lifesciences Ltd.
1373.70
8.60 (0.63%)
Natco Pharma Ltd.
865.00
-3.30 (0.38%)
Jubilant Pharmova Ltd.
971.95
14.60 (1.53%)
Caplin Point Laboratories Ltd.
2255.20
144.20 (6.83%)
Dr. Agarwal's Health Care Ltd.
448.50
-3.10 (0.69%)
Alembic Pharmaceuticals Ltd.
731.50
-14.00 (1.88%)
Cohance Lifesciences FAQs
The Buying Price of Cohance Lifesciences share is 431.9 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Cohance Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Cohance Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Cohance Lifesciences shares is 90.54. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Cohance Lifesciences shares is 4.15. Useful to assess the stock's value relative to its book value.
To assess Cohance Lifesciences’s valuation compare Sector P/E, P/B which are 67.41 & 2.96 with sector averages, along with growth rates and financial metrics.
The Market Cap of Cohance Lifesciences is 16523.07 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Cohance Lifesciences share price is 1121.15 & 266.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Cohance Lifesciences belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
